-The Times of India   In a bid to induce a fresh life into the ailing health services delivery system in Uttar Pradesh, the World Bank has signed a $152 million deal with the Central and UP governments. The funds will be used to finance the government's efforts to improve the efficiency, quality, and accountability of health services in the state. The project, called the Uttar Pradesh Health Systems Strengthening Project (UPHSSP) for...

Punctuality audit ordered by the Chief Secretary of the Delhi government last year opened the Pandora’s Box on poor attendance records of government officials. Documents obtained under an RTI filed by Pratidhi show that nodal departments had large numbers of their staff members missing, on most surprise checks. Chief secretary P K Tripathi had ordered the audit last June after writing to heads of all departments that they must conduct at...

The Budget provides proof of the United Progressive Alliance government having forgotten the importance of its own “flagship schemes”. BUDGET 2012-13 provides conclusive proof that the United Progressive Alliance (UPA) government has lost its way. It has managed the remarkable feat of upsetting almost everyone and making no one happy. The Budget is highly regressive in both taxation and spending terms and will raise prices of essentials, so aam aurat and...

One man’s fiscal problem is another man’s lifeline. Trigger happy bureaucrats and economists may love shooting down subsidies because it bloats the fiscal deficit and burdens the government but the simple fact is that in a one billion strong nation, in which nearly one in every three live below the poverty line, one needs an effective and efficient method through which privileged tax payers can support the poor. Last week, finance...

India's decision this month to produce Germany-based multinational Bayer's anti-cancer drug Nexavar, in the first use of "compulsory licensing" in South Asia, will save lives but also raises intricate questions. Under the compulsory licensing process, a government can under World Trade Organization (WTO) rules bypass a patent owner's rights after three years and order the manufacture and sale of life-saving medicines at much cheaper cost than by obtaining the medicine from...